期刊文献+

HLA-A2型人外周血MAGE-A10特异性T细胞的体外激发及功能检测

Generation of HLA-A2 restricted MAGE-A10 specific T lymphocytes in vitro from PBMC of healthy donors and their function evaluation
下载PDF
导出
摘要 目的:探讨体外激发HLA-A2型人外周血单个核细胞(PBMC)中的MAG-E-A10(254-262)特异性T淋巴细胞及其功能检测方法。方法:分别采用肽段MAGE-A-10(254-262)直接刺激PBMC的Bulk Culture法和自体DC负载肽段MAGE-A10(254-262)刺激CD3+CD8+法,均经3次刺激进行体外扩增tetramer-MAGE-A10(254-262)阳性T细胞。以人流感病毒肽段flu-matrix(58-66)为阳性对照。Intracellular staining法检测其针对MAGE-A10(254-262)的穿孔素、颗粒酶B的分泌能力。结果:HLA-A2型PBMC用BuckCulture或DC负载肽段刺激CD3+CD8+法培养,激发的tetramer-flu阳性T细胞率均>10%,DC法激发的tetramer-flu阳性T细胞率显著高于Buck Culture,t=9.79,P<0.01。Bulk Culture法得到的阳性T细胞率分别为0.01%和0.02%,DC法则分别是0.05%和0.12%。Sorting得到的tetram-er-MAGE-A10(254-262)阳性T细胞,效靶比为10∶1时其特异性杀伤为46%,细胞针对MAGE-A10(254-262)分泌穿孔素、颗粒酶B的百分率分别为39%和87%。结论:从捐献的人血细胞中用自体DC负载肽段刺激CD3+CD8+法激发tetramer阳性T细胞的效率优于Bulk Culture法。 OBJECTIVE: To explore the method of generating HLA-A2 restricted MAGE-A10(254-262) specific T lympho cytes in vitro from PBMC of healthy donors. METHODS: Bulk Culture from PBMC and autologous DC loaded with MAGE A 10(254-262) peptide to stimulate CD3^+ CD8^+ T lymphocytes culture were used respectively,with the stimulation for three times to pro liferate tetramer-MAGE-A10(254-262) positive T lymphocytes, and human flu virus peptide flu matrix(58-66) (GILGFVFTV) was set as the positive control. An intracellular staining assay was used for their MAGE-A10(254 -262) specific Perforin/Granzyme B secretion capacities. RESULTS: Both the generating methods for flu matrix(58- 66) obtained tetramer-positive T lymphocytes with the concentration over 10%, and the concentration of obtained positive T lymphocytes from DC stimulation culture was obviously higher than that from Bulk Culture, t=9.79, P〈0.01. By Bulk Culture, 0.01% and 0.02% tetramer positive T lymphocytes were harvested from the two samples while 0.05% and 0.12% tetramer positive T lymphocytes by DC stimulation culture from the same samples. By the functional assays, the sorted tetramer-MAGE-A10(254 -262) positive T lymphocytes showed 46% specific killing effects at effector: target/10 : 1, and 39%/87% of Perforin/ Granzyme B secretion capacities targeted to MAGE-A10(254- 262) positive tumor cells. CONCLUSION: By autologous DC loaded with pep tide to stimulate CD3^+ CD8^+ T lymphocytes culture is more efficient than by Bulk Culture to generate tetramer positive T lymphocytes from healthy donor blood.
出处 《中华肿瘤防治杂志》 CAS 2008年第21期1647-1650,1673,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 Ludwig Institute for Cancer Research,The Cancer Research Institute,The Swiss National Science Foundation 广东省自然科学基金(031722)
关键词 抗原特异性 T细胞 MAGE-A10(254-262)四聚体 功能试验 antigen specific T lymphocyte tetramer-MAGE-A10(254-262) functional assay
  • 相关文献

参考文献15

  • 1Mizukami Y, Kono K, Daigo Y, et al. Detection of novel cancer testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma[J]. Cancer Sci, 2008, 99(7):-1448 1454.
  • 2Felix K, Mathias S, Bernhard A, et al. Analysis of antigen-specific T-Cell responses with synthetic peptides-What kind of peptide for which purpose? [J]. Human Immunology, 2004, 65 (5) : 523- 536.
  • 3Moss P, Khan N. CD8^+ T-cell immunity to cytomegalovirus[J]. Immunology, 2004, 65(5):456- 464.
  • 4Suzuki S, Sasajima K, Sato Y, et al. MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer[J]. Br J Cancer, 2008,99(2) :350- 356.
  • 5Scanlan M J, Gure A O, Jungbluth A A, et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy [J]. Immunol Rev, 2002, 188(1):22- 32.
  • 6Sartorius R, Pisu P, D'Apice L, et al. The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses [J]. J Immunol, 2008,180(6) :3719-3728.
  • 7Groeper C, Gambazzi F, Zajac P, et al. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer[J]. Int J Cancer, 2007,120(2) :337-343.
  • 8Danila V, Valerie D, Verena R G, et al. Frequent cytolytic T-cell responses to peptide MAGE-A10254 262 in melanoma [J]. Cancer Research, 2001, 61(2) : 509-512.
  • 9任会均,张锦堃,周玲,左建民,魏锡云,曾毅.冻融人树突状细胞基因疫苗体外抗肿瘤免疫效应[J].中华肿瘤防治杂志,2007,14(12):884-887. 被引量:5
  • 10Le Gal F A, Widmer V M, Dutoit V, et ah Tissue homing and persistence of defined antigen specific CD8^+ tumor-reactive T- cell clones in long-term melanoma survivors[J]. J Invest Dermatol, 2007, 127(3) :622-629.

二级参考文献7

  • 1任会均,张锦堃,陈东晓,李军,魏锡云.转染HPV16E6基因人树突状细胞疫苗的制备及生物学特性[J].中国免疫学杂志,2006,22(11):1032-1035. 被引量:2
  • 2Pan Y,Zhang J K,Zhou L,et al.In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus[J].BBRC,2006,347(4):551-557.
  • 3Hayashi T,Nakao K,Nagayama Y,et al.Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models[J].Int J Oncol,2005,26(5):1313-1319.
  • 4Caruso D A,Orme L M,Amor G M,et al.Results of a Phase Ⅰ study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma[J].Cancer,2005,103(6):1280-1291.
  • 5Santin A D,Bellone S,Palmieri M,et al.Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix[J].Gynecol Oncol,2003,89(2):271-280.
  • 6Kawa K.Epstein-Barr virus-associated diseases in humans[J].Int J Hematol,2000,71(2):108-117.
  • 7Indrova M,Reinis M,Bubenik J,et al.Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines:CTL activation and protective effects[J].Folia Biol(Praha),2004,50(6):184-193.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部